JapanStake
Pharmaceutical · Fiscal year end Dec 31

Veritas In Silico Inc.

130A

株式会社Veritas In Silico

FIGI BBG00JM64265130A.T130A JPCorp. no. 4011001113744

Latest half-year results

First half · fiscal year to 2026-12 · filed 2026-08-07

For the first half of the fiscal year to 2026-12: Revenue ¥0 billion (-15.5% YoY), Ordinary income ¥-0.2 billion, Net income ¥-0.4 billion.

This periodYear on year
Revenue¥37m-15.5%
Ordinary profit−¥243m—
Net profit to owners−¥387m—

From the securities report on EDINET, which states no forecast. History via /v1/companies/130A/earnings-releases.

Financials

Japan GAAP · non-consolidated · fiscal year to 2025-12-31
Revenue
¥91m
Net income
−¥426m
ROE
—
Equity ratio
94.6%
Dividend / share
—
Employees
19
Revenue · ¥m
FY2021: ¥59m 59.3 FY2021FY2022: ¥179m 179 FY2022FY2023: ¥360m 360 FY2023FY2024: ¥195m 195 FY2024FY2025: ¥91m 91.1 FY2025
Net income · ¥m
FY2021: −¥232m -232 FY2021FY2022: −¥141m -141 FY2022FY2023: ¥33m 33 FY2023FY2024: −¥236m -236 FY2024FY2025: −¥426m -426 FY2025
Fiscal yearRevenueNet incomeTotal assetsNet assetsROEEPSOperating CF
2025-12-31¥91m−¥426m¥1,885m¥1,784m—¥-65.62−¥299m
2024-12-31¥195m−¥236m¥2,249m¥2,210m—¥-37.11−¥218m
2023-12-31¥360m¥33m¥1,656m¥1,576m2.1%¥6.01¥69m
2022-12-31¥179m−¥141m¥1,599m¥1,543m—¥-25.7−¥149m
2021-12-31¥59m−¥232m¥1,755m¥1,684m—¥-51.92−¥235m

Indicators

Computed by us from filings · fiscal year to 2025-12-31
MetricValuePercentile among listed companies
ROE, %——
Ordinary margin-4.2860.5
Equity ratio, %94.699.8
Revenue growth-0.53180.5
Net income growth-0.80038.5
Operating cash flow / assets-0.15883.2
Policy-uncertainty measure0.51 Share of the report's text discussing policy-related uncertainty, by policy area. Proprietary text method.
Trade & tariffs 1 Politics & geopolitics 1
Ownership activity 0 filer(s) stated they may make proposals in 365 days; 0 new 5% holder(s) in 180 days; net stake change 0.00pt in 90 days; 11.3% held by other listed companies.

Results wording balance: +0.50. Proprietary text method; it describes the wording only and does not interpret context.

Via /v1/companies/130A/indicators. Descriptive figures, not a rating and not investment advice.

From other filings

As the company states them
Internal control, 2026-03-23: see filing 上記の評価の結果、当事業年度末時点において、当社の財務報告に係る内部統制は有効であると判断しました。 Filing

Segments, votes and tender offers

Stated in EDINET filings
Latest voting result: 2026-03-24 · 取締役5名選任の件 · passed. /v1/companies/130A/voting

Ownership changes

All companies →
  • 2025-06-23
    Decrease−1.04pt

    individual filer reduced holdings in Veritas In Silico Inc. (130A) to 6.74% from 7.78%.

    01020304050
  • 2025-06-23
    Decrease−1.70pt

    individual filer reduced holdings in Veritas In Silico Inc. (130A) to 5.04% from 6.74%.

    01020304050
  • 2025-06-23
    Below 5%−1.09pt

    individual filer cut holdings in Veritas In Silico Inc. (130A) to 3.95% from 5.04%, below the 5% threshold.

    01020304050
  • 2024-10-16
    Amendment−0.65pt

    individual filer filed a correction to a 5% report on Veritas In Silico Inc. (130A).

  • 2024-09-03
    Decrease−0.65pt

    individual filer reduced holdings in Veritas In Silico Inc. (130A) to 21.89% from 22.54%.

    01020304050
  • 2024-05-14
    Decrease−0.24pt

    Mitsubishi UFJ Financial Group Inc. reduced holdings in Veritas In Silico Inc. (130A) to 7.90% from 8.14%.

    01020304050
  • 2024-02-16
    New 5% stake

    Shinsei Capital Partners, Ltd. Nakamura Manabu disclosed a 8.83% stake in Veritas In Silico Inc. (130A), crossing the 5% reporting threshold.

    01020304050
  • 2024-02-16
    New 5% stake

    Mitsubishi UFJ Financial Group Inc. disclosed a 8.14% stake in Veritas In Silico Inc. (130A), crossing the 5% reporting threshold.

    01020304050
  • 2024-02-14
    New 5% stake

    individual filer disclosed a 22.54% stake in Veritas In Silico Inc. (130A), crossing the 5% reporting threshold.

    01020304050
  • 2024-02-14
    Threshold

    Holdings of individual filer in Veritas In Silico Inc. (130A) moved above 10% (new -> 22.54%).

    01020304050

Trades by 5% holders

From the 60-day trade tables in 5% reports
HolderPeriodNet sharesNet % of sharesAvg. filed priceRange
individual filer2025-06-10 – 2025-06-20-176,800−2.71pt——

Net shares and the average are our calculations. Prices are filed prices as stated by the filer, mostly for off-market trades; they are not market prices. Stock lending, custody transfers and option exercises are excluded from net shares. Every row via /v1/companies/130A/trades.

5% filings

Large shareholding reports on 130A
FiledFilerStakeChangeStated purpose
2025-06-23individual filer6.74%−1.04pt—
2025-06-23individual filer5.04%−1.70pt—
2025-06-23individual filer3.95%−1.09pt—
2024-10-16individual filer21.89%−0.65pt—
2024-09-03individual filer21.89%−0.65pt—
2024-07-23Mitsubishi UFJ Financial Group, Inc.7.90%0.00ptpure investment
2024-05-14Mitsubishi UFJ Financial Group, Inc.7.90%−0.24ptpure investment
2024-02-16Shinsei Capital Partners, Ltd. Nakamura Manabu8.83%—pure investment
2024-02-16Mitsubishi UFJ Financial Group, Inc.8.14%—pure investment
2024-02-14individual filer22.54%——

Cross-shareholdings

From the annual report's status of shareholdings
Listed strategic holdings
— issues
Book value
—
Sold in the year
— — issues
Bought in the year
— — issues
Mutual, both reports
0
Held by listed cos.
2

Held by: MITSUBISHI GAS CHEMICAL COMPANY,INC. 4182, KDDI CORPORATION 9433

Purposes, all holdings and mutual flags via /v1/companies/130A/cross-holdings. Share changes include stock splits.

Major shareholders

As of fiscal year end 2025-12-31
ShareholderSharesRatio
individual holder1,400,00021.60%
三菱瓦斯化学株式会社731,25611.30%
New Life Science1号投資事業有限責任組合556,4448.60%
三菱UFJライフサイエンス1号投資事業有限責任組合512,6407.90%
IEファスト&エクセレント投資事業有限責任組合331,7005.10%
individual holder298,3904.60%
楽天証券株式会社131,9002.00%
Nomura PB Nominees Limited Omnibus-Margin (CashPB)116,9001.80%
みずほライフサイエンス第1号投資事業有限責任組合75,2001.20%
株式会社SBI証券61,4230.90%

Get this as JSON

GET /v1/companies/130A
GET /v1/companies/130A/financials
GET /v1/companies/130A/details
GET /v1/companies/130A/segments
GET /v1/companies/130A/voting
GET /v1/companies/130A/tender-offers
GET /v1/companies/130A/indicators
GET /v1/companies/130A/earnings-releases
GET /v1/events?ticker=130A
GET /v1/companies/130A/trades         
GET /v1/companies/130A/cross-holdings 
GET /v1/companies/130A/brief          

Plans from $9 a month · Documentation